{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:58:51Z","timestamp":1792789131745,"version":"4.5.0"},"reference-count":354,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.canlet.2023.216066","type":"journal-article","created":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T17:45:23Z","timestamp":1673718323000},"page":"216066","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Nanoparticles in the diagnosis and treatment of cancer metastases: Current and future perspectives"],"prefix":"10.1016","volume":"556","author":[{"given":"Mangala","family":"Hegde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikunj","family":"Naliyadhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyothsna","family":"Unnikrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed S.","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sosmitha","family":"Girisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8677-8475","authenticated-orcid":false,"given":"Gautam","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajaikumar B.","family":"Kunnumakkara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2023.216066_bib1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrc3180","article-title":"Treating metastatic cancer with nanotechnology","volume":"12","author":"Schroeder","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2023.216066_bib2","first-page":"258","article-title":"Emerging strategies for treating metastasis","volume":"2","author":"Esposito","year":"2021","journal-title":"Nat. Can. (Que.)"},{"key":"10.1016\/j.canlet.2023.216066_bib3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","article-title":"Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study","volume":"88","author":"Sadeghi","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2023.216066_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.650098","article-title":"Peritoneal metastases from colorectal cancer: defining and addressing the challenges","volume":"11","author":"Kranenburg","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1245\/s10434-008-0234-2","article-title":"Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis","volume":"16","author":"Koh","year":"2009","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib6","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.amjsurg.2013.12.024","article-title":"Preoperative computed tomography does not predict resectability in peritoneal carcinomatosis","volume":"207","author":"Rivard","year":"2014","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.canlet.2023.216066_bib7","first-page":"35","article-title":"Superparamagnetic iron oxide based MRI contrast agents: current status of clinical application","volume":"1","author":"Wang","year":"2011","journal-title":"Quant. Imag. Med. Surg."},{"key":"10.1016\/j.canlet.2023.216066_bib8","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.addr.2012.06.012","article-title":"Tumor-targeting multi-functional nanoparticles for theragnosis: new paradigm for cancer therapy","volume":"64","author":"Ryu","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.canlet.2023.216066_bib9","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1166\/jbn.2014.1896","article-title":"Applications of nanoparticles for brain cancer imaging and therapy","volume":"10","author":"Zhang","year":"2014","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.canlet.2023.216066_bib10","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20150207","article-title":"Applications of nanoparticles for diagnosis and therapy of cancer","volume":"88","author":"Baetke","year":"2015","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.canlet.2023.216066_bib11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.canlet.2016.10.032","article-title":"The application of nanoparticles in diagnosis and theranostics of gastric cancer","volume":"386","author":"Li","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2023.216066_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/10717544.2014.913325","article-title":"Potential of targeted drug delivery system for the treatment of bone metastasis","volume":"23","author":"Vinay","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.canlet.2023.216066_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120404","article-title":"Targeting nanoparticles for diagnosis and therapy of bone tumors: opportunities and challenges","volume":"265","author":"Gao","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2023.216066_bib14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2016.01.009","article-title":"PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time","volume":"224","author":"Kooijmans","year":"2016","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.canlet.2023.216066_bib15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.addr.2016.05.021","article-title":"Radiation effects on the tumor microenvironment: implications for nanomedicine delivery","volume":"109","author":"Stapleton","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.canlet.2023.216066_bib16","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nrc1893","article-title":"Drug penetration in solid tumours","volume":"6","author":"Minchinton","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2023.216066_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094673","article-title":"Drug resistance in metastatic breast cancer: tumor targeted nanomedicine to the rescue","volume":"22","author":"Gote","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2023.216066_bib18","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/mc.22021","article-title":"CD44\/cellular prion protein interact in multidrug resistant breast cancer cells and correlate with responses to neoadjuvant chemotherapy in breast cancer patients","volume":"53","author":"Cheng","year":"2014","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.canlet.2023.216066_bib19","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/sj.bjc.6605185","article-title":"Coexpression of invasive markers (uPA, CD44) and multiple drug-resistance proteins (MDR1, MRP2) is correlated with epithelial ovarian cancer progression","volume":"101","author":"Chen","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2023.216066_bib20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.critrevonc.2018.09.017","article-title":"Crosstalk in cancer resistance and metastasis","volume":"132","author":"Norouzi","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.canlet.2023.216066_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.101004","article-title":"Nanomedicines inhibiting tumor metastasis and recurrence and their clinical applications","volume":"36","author":"Kong","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.canlet.2023.216066_bib22","first-page":"1","article-title":"Metal nanoparticles in cancer: from synthesis and metabolism to cellular interactions","author":"Tuli","year":"2022","journal-title":"Journal of Nanostructure in Chemistry"},{"key":"10.1016\/j.canlet.2023.216066_bib23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.tips.2019.04.002","article-title":"Adding nanotechnology to the metastasis treatment arsenal","volume":"40","author":"Banerjee","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.canlet.2023.216066_bib24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.biomaterials.2017.10.024","article-title":"Overcoming obstacles in the tumor microenvironment: recent advancements in nanoparticle delivery for cancer theranostics","volume":"156","author":"Overchuk","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2023.216066_bib25","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.chempr.2019.05.024","article-title":"Size-tunable assemblies based on ferrocene-containing DNA polymers for spatially uniform penetration","volume":"5","author":"Tan","year":"2019","journal-title":"Chem"},{"key":"10.1016\/j.canlet.2023.216066_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119840","article-title":"A NIR light triggered disintegratable nanoplatform for enhanced penetration and chemotherapy in deep tumor tissues","volume":"245","author":"Xiong","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2023.216066_bib27","article-title":"A size-changeable collagenase-modified nanoscavenger for increasing penetration and retention of nanomedicine in deep tumor tissue","volume":"32","author":"Xu","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.canlet.2023.216066_bib28","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1002\/anie.201900135","article-title":"Microenvironment-induced in situ self-assembly of polymer-peptide conjugates that attack solid tumors deeply","volume":"58","author":"Cong","year":"2019","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.canlet.2023.216066_bib29","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.apsb.2018.09.001","article-title":"Theranostic nanoparticles with tumor-specific enzyme-triggered size reduction and drug release to perform photothermal therapy for breast cancer treatment","volume":"9","author":"Liu","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.canlet.2023.216066_bib30","doi-asserted-by":"crossref","first-page":"579","DOI":"10.7150\/thno.48811","article-title":"MRI-traceable theranostic nanoparticles for targeted cancer treatment","volume":"11","author":"Anani","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2023.216066_bib31","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.addr.2014.07.009","article-title":"Targeted multimodal imaging modalities","volume":"76","author":"Lee","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.canlet.2023.216066_bib32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/MED.0000000000000574","article-title":"Multimodal imaging of thyroid cancer","volume":"27","author":"Brauckhoff","year":"2020","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.canlet.2023.216066_bib33","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jot.2015.07.004","article-title":"Multimodal imaging of bone metastases: from preclinical to clinical applications","volume":"3","author":"Ellmann","year":"2015","journal-title":"J Orthop Translat"},{"key":"10.1016\/j.canlet.2023.216066_bib34","article-title":"Imaging of spinal metastatic disease","author":"Shah","year":"2011","journal-title":"Int J Surg Oncol"},{"key":"10.1016\/j.canlet.2023.216066_bib35","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S1470-2045(09)70088-9","article-title":"Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis","volume":"10","author":"Costelloe","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119553","article-title":"Radiolabeling nanomaterials for multimodality imaging: new insights into nuclear medicine and cancer diagnosis","volume":"228","author":"Ge","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2023.216066_bib37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00109-013-1108-z","article-title":"Brain metastases from breast cancer: lessons from experimental magnetic resonance imaging studies and clinical implications","volume":"92","author":"Murrell","year":"2014","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.canlet.2023.216066_bib38","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1007\/s00330-019-06524-x","article-title":"Diagnostic performance of imaging for the detection of peritoneal metastases: a meta-analysis","volume":"30","author":"van 't Sant","year":"2020","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.canlet.2023.216066_bib39","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1148\/rg.2019180114","article-title":"MRI of rectal cancer: tumor staging, imaging techniques, and management","volume":"39","author":"Horvat","year":"2019","journal-title":"Radiographics"},{"key":"10.1016\/j.canlet.2023.216066_bib40","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1148\/radiol.2331030777","article-title":"Whole-body MR imaging: evaluation of patients for metastases","volume":"233","author":"Lauenstein","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.canlet.2023.216066_bib41","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/107327481201900204","article-title":"Diagnostic imaging and image-guided therapy of skeletal metastases","volume":"19","author":"Choi","year":"2012","journal-title":"Cancer Control"},{"key":"10.1016\/j.canlet.2023.216066_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/polym13172989","article-title":"Recent advances in multimodal molecular imaging of cancer mediated by hybrid magnetic nanoparticles","volume":"13","author":"Luengo Morato","year":"2021","journal-title":"Polymers"},{"key":"10.1016\/j.canlet.2023.216066_bib43","article-title":"Multimodal nanoparticle imaging agents: design and applications","volume":"375","author":"Burke","year":"2017","journal-title":"Philos Trans A Math Phys Eng Sci"},{"key":"10.1016\/j.canlet.2023.216066_bib44","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s12645-012-0029-9","article-title":"Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horse","volume":"3","author":"Choi","year":"2012","journal-title":"Cancer Nanotechnol"},{"key":"10.1016\/j.canlet.2023.216066_bib45","doi-asserted-by":"crossref","first-page":"8012","DOI":"10.1021\/acsnano.5b01552","article-title":"Spatiotemporal targeting of a dual-ligand nanoparticle to cancer metastasis","volume":"9","author":"Doolittle","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.canlet.2023.216066_bib46","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1056\/NEJMoa022749","article-title":"Noninvasive detection of clinically occult lymph-node metastases in prostate cancer","volume":"348","author":"Harisinghani","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2023.216066_bib47","doi-asserted-by":"crossref","first-page":"15803","DOI":"10.1021\/acsami.5b02831","article-title":"17beta-Estradiol-Loaded PEGlyated upconversion nanoparticles as a bone-targeted drug nanocarrier","volume":"7","author":"Hu","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.canlet.2023.216066_bib48","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1016\/j.biomaterials.2012.02.060","article-title":"Long-term multimodal imaging of tumor draining sentinel lymph nodes using mesoporous silica-based nanoprobes","volume":"33","author":"Huang","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2023.216066_bib49","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/s41551-017-0167-9","article-title":"Surveillance nanotechnology for multi-organ cancer metastases","volume":"1","author":"Kantamneni","year":"2017","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.canlet.2023.216066_bib50","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1021\/nn205070h","article-title":"Targeting of primary breast cancers and metastases in a transgenic mouse model using rationally designed multifunctional SPIONs","volume":"6","author":"Kievit","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/j.canlet.2023.216066_bib51","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/jmri.20852","article-title":"A dendrimer-based nanosized contrast agent dual-labeled for magnetic resonance and optical fluorescence imaging to localize the sentinel lymph node in mice","volume":"25","author":"Koyama","year":"2007","journal-title":"J. Magn. Reson. Imag."},{"key":"10.1016\/j.canlet.2023.216066_bib52","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12951-020-0573-0","article-title":"Gold nanoparticle based double-labeling of melanoma extracellular vesicles to determine the specificity of uptake by cells and preferential accumulation in small metastatic lung tumors","volume":"18","author":"Lara","year":"2020","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.canlet.2023.216066_bib53","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10549-006-9199-7","article-title":"LHRH-conjugated magnetic iron oxide nanoparticles for detection of breast cancer metastases","volume":"99","author":"Leuschner","year":"2006","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.canlet.2023.216066_bib54","article-title":"Engineered multifunctional nanomedicine for simultaneous stereotactic chemotherapy and inhibited osteolysis in an orthotopic model of bone metastasis","volume":"29","author":"Li","year":"2017","journal-title":"Adv. Mater."},{"key":"10.1016\/j.canlet.2023.216066_bib55","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/j.nano.2018.04.018","article-title":"In vivo near infrared fluorescence imaging and dynamic quantification of pancreatic metastatic tumors using folic acid conjugated biodegradable mesoporous silica nanoparticles","volume":"14","author":"Li","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.canlet.2023.216066_bib56","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.colsurfb.2016.03.015","article-title":"Alendronate conjugated nanoparticles for calcification targeting","volume":"142","author":"Li","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.canlet.2023.216066_bib57","doi-asserted-by":"crossref","first-page":"26064","DOI":"10.1021\/acsami.8b09142","article-title":"Highly sensitive fluorescence and photoacoustic detection of metastatic breast cancer in mice using dual-modal nanoprobes","volume":"10","author":"Lin","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.canlet.2023.216066_bib58","doi-asserted-by":"crossref","first-page":"15212","DOI":"10.1021\/acsami.8b21679","article-title":"Zwitterionic gadolinium(III)-Complexed dendrimer-entrapped gold nanoparticles for enhanced computed tomography\/magnetic resonance imaging of lung cancer metastasis","volume":"11","author":"Liu","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.canlet.2023.216066_bib59","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1021\/nn400669r","article-title":"Inherently multimodal nanoparticle-driven tracking and real-time delineation of orthotopic prostate tumors and micrometastases","volume":"7","author":"Liu","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.canlet.2023.216066_bib60","doi-asserted-by":"crossref","first-page":"7750","DOI":"10.1073\/pnas.1605841113","article-title":"Theranostic near-infrared fluorescent nanoplatform for imaging and systemic siRNA delivery to metastatic anaplastic thyroid cancer","volume":"113","author":"Liu","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2023.216066_bib61","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.nano.2016.09.002","article-title":"Phage display-derived oligopeptide-functionalized probes for in vivo specific photoacoustic imaging of osteosarcoma","volume":"13","author":"Ma","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.canlet.2023.216066_bib62","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s41181-016-0017-1","article-title":"Bone targeting compounds for radiotherapy and imaging: *Me(III)-DOTA conjugates of bisphosphonic acid, pamidronic acid and zoledronic acid","volume":"1","author":"Meckel","year":"2017","journal-title":"EJNMMI Radiopharm Chem"},{"key":"10.1016\/j.canlet.2023.216066_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248531","article-title":"Intraoperative laparoscopic detection of sentinel lymph nodes with indocyanine green and superparamagnetic iron oxide in a swine gallbladder cancer model","volume":"16","author":"Mihara","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2023.216066_bib64","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1073\/pnas.0910283107","article-title":"Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases","volume":"107","author":"Olson","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2023.216066_bib65","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1021\/acsami.0c21620","article-title":"Antifouling dendrimer-entrapped copper sulfide nanoparticles enable photoacoustic imaging-guided targeted combination therapy of tumors and tumor metastasis","volume":"13","author":"Ouyang","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.canlet.2023.216066_bib66","doi-asserted-by":"crossref","first-page":"8783","DOI":"10.1021\/nn303833p","article-title":"Imaging metastasis using an integrin-targeting chain-shaped nanoparticle","volume":"6","author":"Peiris","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/j.canlet.2023.216066_bib67","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009524","article-title":"Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe","volume":"6","author":"Phillips","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2023.216066_bib68","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/adhm.201300061","article-title":"Antibody-functionalized magnetic polymersomes: in vivo targeting and imaging of bone metastases using high resolution MRI","volume":"2","author":"Pourtau","year":"2013","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.canlet.2023.216066_bib69","doi-asserted-by":"crossref","first-page":"7259","DOI":"10.1021\/acsnano.7b03197","article-title":"Targeting osteocytes to attenuate early breast cancer bone metastasis by theranostic upconversion nanoparticles with responsive plumbagin release","volume":"11","author":"Qiao","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.canlet.2023.216066_bib70","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1021\/nn507433p","article-title":"Ultrasensitive in vivo detection of primary gastric tumor and lymphatic metastasis using upconversion nanoparticles","volume":"9","author":"Qiao","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.canlet.2023.216066_bib71","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1039\/C6TB02552H","article-title":"A traceable and bone-targeted nanoassembly based on defect-related luminescent mesoporous silica for enhanced osteogenic differentiation","volume":"5","author":"Ren","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.canlet.2023.216066_bib72","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12951-016-0233-6","article-title":"Targeted drug delivery of near IR fluorescent doxorubicin-conjugated poly(ethylene glycol) bisphosphonate nanoparticles for diagnosis and therapy of primary and metastatic bone cancer in a mouse model","volume":"14","author":"Rudnick-Glick","year":"2016","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.canlet.2023.216066_bib73","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12951-015-0126-0","article-title":"Near IR fluorescent conjugated poly(ethylene glycol)bisphosphonate nanoparticles for in vivo bone targeting in a young mouse model","volume":"13","author":"Rudnick-Glick","year":"2015","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.canlet.2023.216066_bib74","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s11307-016-0932-2","article-title":"Detection of lymph node metastases with SERRS nanoparticles","volume":"18","author":"Spaliviero","year":"2016","journal-title":"Mol. Imag. Biol."},{"key":"10.1016\/j.canlet.2023.216066_bib75","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s10120-006-0365-8","article-title":"Preoperative diagnosis of lymph node metastases in gastric cancer by magnetic resonance imaging with ferumoxtran-10","volume":"9","author":"Tatsumi","year":"2006","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.canlet.2023.216066_bib76","doi-asserted-by":"crossref","DOI":"10.4172\/2157-7439.1000112","article-title":"Development of secreted protein and acidic and rich in cysteine (SPARC) targeted nanoparticles for the prognostic molecular imaging of metastatic prostate cancer","volume":"2","author":"Thomas","year":"2011","journal-title":"J. Nanomed. Nanotechnol."},{"issue":"Suppl 3","key":"10.1016\/j.canlet.2023.216066_bib77","doi-asserted-by":"crossref","first-page":"S923","DOI":"10.1245\/s10434-015-4594-0","article-title":"Theranostic photosensitive nanoparticles for lymph node metastasis of gastric cancer","volume":"22","author":"Tsujimoto","year":"2015","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib78","article-title":"Camouflaging nanoparticles with brain metastatic tumor cell membranes: a new strategy to traverse blood\u2013brain barrier for imaging and therapy of brain tumors","volume":"30","author":"Wang","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.canlet.2023.216066_bib79","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/08982104.2014.928890","article-title":"cRGD-conjugated magnetic-fluorescent liposomes for targeted dual-modality imaging of bone metastasis from prostate cancer","volume":"25","author":"Wang","year":"2015","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.canlet.2023.216066_bib80","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.biomaterials.2018.08.033","article-title":"Multifunctional melanin-like nanoparticles for bone-targeted chemo-photothermal therapy of malignant bone tumors and osteolysis","volume":"183","author":"Wang","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2023.216066_bib81","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201801331","article-title":"Self-assembled semiconducting polymer nanoparticles for ultrasensitive near-infrared afterglow imaging of metastatic tumors","volume":"30","author":"Xie","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.canlet.2023.216066_bib82","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1021\/acs.nanolett.0c04967","article-title":"Glutathione-responsive magnetic nanoparticles for highly sensitive diagnosis of liver metastases","volume":"21","author":"Xu","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.canlet.2023.216066_bib83","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.1002\/adfm.201502003","article-title":"Imaging\u2010guided combined photothermal and radiotherapy to treat subcutaneous and metastatic tumors using iodine\u2010131\u2010doped copper sulfide nanoparticles","volume":"25","author":"Yi","year":"2015","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.canlet.2023.216066_bib84","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1166\/jbn.2014.1812","article-title":"Development of novel nanoparticle for bone cancer","volume":"10","author":"Patricio","year":"2014","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.canlet.2023.216066_bib85","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1039\/b9nr00317g","article-title":"Preparation of functionalized gold nanoparticles as a targeted X-ray contrast agent for damaged bone tissue","volume":"2","author":"Zhang","year":"2010","journal-title":"Nanoscale"},{"key":"10.1016\/j.canlet.2023.216066_bib86","doi-asserted-by":"crossref","first-page":"8887","DOI":"10.1039\/D1CS00083G","article-title":"Fluorescence imaging of pathophysiological microenvironments","volume":"50","author":"Wang","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.canlet.2023.216066_bib87","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/odi.13071","article-title":"Optical fluorescence imaging in oral cancer and potentially malignant disorders: a systematic review","volume":"26","author":"Tiwari","year":"2020","journal-title":"Oral Dis."},{"key":"10.1016\/j.canlet.2023.216066_bib88","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.1002\/anie.202000947","article-title":"Tumor microenvironment-activated NIR-II nanotheranostic system for precise diagnosis and treatment of peritoneal metastasis","volume":"59","author":"Ling","year":"2020","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.canlet.2023.216066_bib89","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201901224","article-title":"Specific small-molecule NIR-II fluorescence imaging of osteosarcoma and lung metastasis","volume":"9","author":"Zhou","year":"2020","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.canlet.2023.216066_bib90","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1021\/acscentsci.9b00220","article-title":"In vivo multicolor imaging with fluorescent probes revealed the dynamics and function of osteoclast proton pumps","volume":"5","author":"Minoshima","year":"2019","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.canlet.2023.216066_bib91","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1021\/acs.nanolett.9b00140","article-title":"High affinity to skeleton rare earth doped nanoparticles for near-infrared II imaging","volume":"19","author":"He","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.canlet.2023.216066_bib92","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1101\/gad.1047403","article-title":"Molecular imaging in living subjects: seeing fundamental biological processes in a new light","volume":"17","author":"Massoud","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2023.216066_bib93","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0959-4388(00)00259-2","article-title":"Complementary emerging techniques: high-resolution PET and MRI","volume":"11","author":"Jacobs","year":"2001","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.canlet.2023.216066_bib94","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.molonc.2012.02.005","article-title":"Molecular imaging for personalized cancer care","volume":"6","author":"Kircher","year":"2012","journal-title":"Mol Oncol"},{"key":"10.1016\/j.canlet.2023.216066_bib95","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1200\/JCO.2006.06.8080","article-title":"Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker","volume":"24","author":"Hylton","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib96","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1039\/b900272n","article-title":"Superparamagnetic nanoparticles as targeted probes for diagnostic and therapeutic applications","author":"Xu","year":"2009","journal-title":"Dalton Trans."},{"key":"10.1016\/j.canlet.2023.216066_bib97","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.addr.2009.11.002","article-title":"Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging","volume":"62","author":"Veiseh","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.canlet.2023.216066_bib98","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12020147","article-title":"Recent advancements of magnetic nanomaterials in cancer therapy","volume":"12","author":"Mukherjee","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.canlet.2023.216066_bib99","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.biomaterials.2017.05.013","article-title":"Surface design of magnetic nanoparticles for stimuli-responsive cancer imaging and therapy","volume":"136","author":"Kang","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2023.216066_bib100","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1021\/acs.accounts.7b00407","article-title":"Magnetic nanomaterials: chemical design, synthesis, and potential applications","volume":"51","author":"Zhu","year":"2018","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.canlet.2023.216066_bib101","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.2174\/0929867324666170830095553","article-title":"Nanoparticles for SPECT and PET imaging: towards personalized medicine and theranostics","volume":"25","author":"Polyak","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.canlet.2023.216066_bib102","doi-asserted-by":"crossref","first-page":"16477","DOI":"10.1021\/ja054905u","article-title":"A bisphosphonate monoamide analogue of DOTA: a potential agent for bone targeting","volume":"127","author":"Kubicek","year":"2005","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.canlet.2023.216066_bib103","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1021\/acs.molpharmaceut.6b00261","article-title":"In vivo bone-targeting of bis(phosphonate)-conjugated double helical RNA monitored by positron emission tomography","volume":"13","author":"Jadhav","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.canlet.2023.216066_bib104","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1118\/1.2757088","article-title":"Functional imaging of cerebrovascular activities in small animals using high-resolution photoacoustic tomography","volume":"34","author":"Yang","year":"2007","journal-title":"Med. Phys."},{"key":"10.1016\/j.canlet.2023.216066_bib105","doi-asserted-by":"crossref","DOI":"10.1063\/1.2195024","article-title":"Photoacoustic imaging in biomedicine","volume":"77","author":"Xu","year":"2006","journal-title":"Rev. Sci. Instrum."},{"key":"10.1016\/j.canlet.2023.216066_bib106","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nbt1220","article-title":"Functional photoacoustic microscopy for high-resolution and noninvasive in vivo imaging","volume":"24","author":"Zhang","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.canlet.2023.216066_bib107","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1088\/0031-9155\/53\/15\/013","article-title":"Noninvasive photoacoustic imaging of the developing vasculature during early tumor growth","volume":"53","author":"Lao","year":"2008","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.canlet.2023.216066_bib108","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.nano.2015.07.007","article-title":"Development of anti-HER2 fragment antibody conjugated to iron oxide nanoparticles for in vivo HER2-targeted photoacoustic tumor imaging","volume":"11","author":"Kanazaki","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.canlet.2023.216066_bib109","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nrclinonc.2014.134","article-title":"Quantitative multimodality imaging in cancer research and therapy","volume":"11","author":"Yankeelov","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib110","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/cncr.29012","article-title":"Multimodal imaging for improved diagnosis and treatment of cancers","volume":"121","author":"Tempany","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2023.216066_bib111","first-page":"1","article-title":"Porphyrin-based metal\u2013organic frameworks: focus on diagnostic and therapeutic applications","author":"Hassanzadeh Goji","year":"2022","journal-title":"Journal of Nanostructure in Chemistry"},{"key":"10.1016\/j.canlet.2023.216066_bib112","doi-asserted-by":"crossref","first-page":"13569","DOI":"10.1021\/acsnano.0c05617","article-title":"Perfluorocarbon@ Porphyrin nanoparticles for tumor hypoxia relief to enhance photodynamic therapy against liver metastasis of colon cancer","volume":"14","author":"Liang","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.canlet.2023.216066_bib113","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.7150\/thno.13451","article-title":"Phototheranostic porphyrin nanoparticles enable visualization and targeted treatment of head and neck cancer in clinically relevant models","volume":"5","author":"Muhanna","year":"2015","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2023.216066_bib114","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10456-013-9344-y","article-title":"Imaging tumor angiogenesis in breast cancer experimental lung metastasis with positron emission tomography, near-infrared fluorescence, and bioluminescence","volume":"16","author":"Zhang","year":"2013","journal-title":"Angiogenesis"},{"key":"10.1016\/j.canlet.2023.216066_bib115","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/wnan.1381","article-title":"Image-guided tumor surgery: will there be a role for fluorescent nanoparticles?","volume":"8","author":"Hill","year":"2016","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"10.1016\/j.canlet.2023.216066_bib116","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1039\/D1BM00088H","article-title":"Sequential SPECT and NIR-II imaging of tumor and sentinel lymph node metastasis for diagnosis and image-guided surgery","volume":"9","author":"Zhang","year":"2021","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.canlet.2023.216066_bib117","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1672","article-title":"Recent advances in applications of nanoparticles in SERS in vivo imaging","volume":"13","author":"Du","year":"2021","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"10.1016\/j.canlet.2023.216066_bib118","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.clinimag.2009.01.013","article-title":"Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy","volume":"33","author":"Ross","year":"2009","journal-title":"Clin. Imag."},{"key":"10.1016\/j.canlet.2023.216066_bib119","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1007\/s00464-014-3608-5","article-title":"A multi-center study of using carbon nanoparticles to track lymph node metastasis in T1-2 colorectal cancer","volume":"28","author":"Yan","year":"2014","journal-title":"Surg. Endosc."},{"key":"10.1016\/j.canlet.2023.216066_bib120","first-page":"68","article-title":"Assessment of lymph node metastasis in elderly patients with colorectal cancer by sentinel lymph node identification using carbon nanoparticles","volume":"23","author":"Sun","year":"2018","journal-title":"J BUON"},{"key":"10.1016\/j.canlet.2023.216066_bib121","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/jjco\/hyaa011","article-title":"The safety and effectiveness of carbon nanoparticles suspension in tracking lymph node metastases of colorectal cancer: a prospective randomized controlled trial","volume":"50","author":"Wang","year":"2020","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib122","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/codi.14538","article-title":"Effect of activated carbon nanoparticles on lymph node harvest in patients with colorectal cancer","volume":"21","author":"Tang","year":"2019","journal-title":"Colorectal Dis."},{"key":"10.1016\/j.canlet.2023.216066_bib123","doi-asserted-by":"crossref","first-page":"9933","DOI":"10.1038\/s41598-021-89541-5","article-title":"Carbon nanoparticle suspension could help get a more accurate nodal staging for patient with rectal cancer","volume":"11","author":"Ge","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2023.216066_bib124","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.1936","article-title":"Use of ultrasmall core-shell fluorescent silica nanoparticles for image-guided sentinel lymph node biopsy in head and neck melanoma: a nonrandomized clinical trial","volume":"4","author":"Zanoni","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.canlet.2023.216066_bib125","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.addr.2019.01.005","article-title":"Iron oxide nanoparticles: diagnostic, therapeutic and theranostic applications","volume":"138","author":"Dadfar","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.canlet.2023.216066_bib126","doi-asserted-by":"crossref","first-page":"7553","DOI":"10.1158\/0008-5472.CAN-10-2070","article-title":"Image-guided breast tumor therapy using a small interfering RNA nanodrug","volume":"70","author":"Kumar","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2023.216066_bib127","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nm1486","article-title":"In vivo imaging of siRNA delivery and silencing in tumors","volume":"13","author":"Medarova","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2023.216066_bib128","first-page":"411","article-title":"MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: the potential for noninvasive diagnosis","volume":"17","author":"Remsen","year":"1996","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.canlet.2023.216066_bib129","doi-asserted-by":"crossref","first-page":"9364","DOI":"10.1016\/j.biomaterials.2011.08.053","article-title":"Polymer encapsulated upconversion nanoparticle\/iron oxide nanocomposites for multimodal imaging and magnetic targeted drug delivery","volume":"32","author":"Xu","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2023.216066_bib130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejps.2017.03.003","article-title":"Encapsulation, controlled release, and antitumor efficacy of cisplatin delivered in liposomes composed of sterol-modified phospholipids","volume":"103","author":"Kieler-Ferguson","year":"2017","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.canlet.2023.216066_bib131","doi-asserted-by":"crossref","first-page":"256","DOI":"10.7150\/thno.22764","article-title":"Multimodal theranostic nanoformulations permit magnetic resonance bioimaging of antiretroviral drug particle tissue-cell biodistribution","volume":"8","author":"Kevadiya","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2023.216066_bib132","article-title":"Bioactive nanoparticles for cancer immunotherapy","volume":"19","author":"Surendran","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2023.216066_bib133","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1166\/jnn.2018.14541","article-title":"Amine-Functionalized silica nanoparticles with drug and gene Co-delivery for anti-angiogenesis therapy of breast cancer","volume":"18","author":"Gong","year":"2018","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.canlet.2023.216066_bib134","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/09205063.2015.1057991","article-title":"Captopril-polyethyleneimine conjugate modified gold nanoparticles for co-delivery of drug and gene in anti-angiogenesis breast cancer therapy","volume":"26","author":"Li","year":"2015","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.canlet.2023.216066_bib135","first-page":"1","article-title":"Nanoscale metal\u2013organic frameworks as smart nanocarriers for cancer therapy","author":"Liu","year":"2022","journal-title":"Journal of Nanostructure in Chemistry"},{"key":"10.1016\/j.canlet.2023.216066_bib136","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jconrel.2019.12.017","article-title":"Stimuli-responsive polymeric prodrug-based nanomedicine delivering nifuroxazide and doxorubicin against primary breast cancer and pulmonary metastasis","volume":"318","author":"Luo","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.canlet.2023.216066_bib137","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nnano.2009.231","article-title":"Golden carbon nanotubes as multimodal photoacoustic and photothermal high-contrast molecular agents","volume":"4","author":"Kim","year":"2009","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.canlet.2023.216066_bib138","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jconrel.2013.10.014","article-title":"Photothermal therapy of tumors in lymph nodes using gold nanorods and near-infrared laser light","volume":"172","author":"Okuno","year":"2013","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.canlet.2023.216066_bib139","doi-asserted-by":"crossref","DOI":"10.1002\/bip.23029","article-title":"Inhibition of melanoma metastasis by dual-peptide PLGA NPS","volume":"108","author":"Arruda","year":"2017","journal-title":"Biopolymers"},{"key":"10.1016\/j.canlet.2023.216066_bib140","article-title":"Activated platelets\u2010targeting micelles with controlled drug release for effective treatment of primary and metastatic triple negative breast cancer","volume":"29","author":"Zhang","year":"2019","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.canlet.2023.216066_bib141","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2217\/nnm-2020-0024","article-title":"Bone-targeted PAMAM nanoparticle to treat bone metastases of lung cancer","volume":"15","author":"Bai","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/j.canlet.2023.216066_bib142","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/aaff96","article-title":"Low-dose curcuminoid-loaded in dextran nanobubbles can prevent metastatic spreading in prostate cancer cells","volume":"30","author":"Bessone","year":"2019","journal-title":"Nanotechnology"},{"key":"10.1016\/j.canlet.2023.216066_bib143","doi-asserted-by":"crossref","first-page":"11397","DOI":"10.1073\/pnas.1301348110","article-title":"Targeted therapy of spontaneous murine pancreatic tumors by polymeric micelles prolongs survival and prevents peritoneal metastasis","volume":"110","author":"Cabral","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2023.216066_bib144","doi-asserted-by":"crossref","first-page":"7738","DOI":"10.1021\/acsnano.6b03148","article-title":"Liposomes coated with isolated macrophage membrane can target lung metastasis of breast cancer","volume":"10","author":"Cao","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.canlet.2023.216066_bib145","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1039\/D0TB00046A","article-title":"Alendronate\/folic acid-decorated polymeric nanoparticles for hierarchically targetable chemotherapy against bone metastatic breast cancer","volume":"8","author":"Chen","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.canlet.2023.216066_bib146","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF02897257","article-title":"Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice","volume":"26","author":"Chiannilkulchai","year":"1990","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.canlet.2023.216066_bib147","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/sct.1989.5.1","article-title":"Doxorubicin-loaded nanoparticles: increased efficiency in murine hepatic metastases","volume":"5","author":"Chiannilkulchai","year":"1989","journal-title":"Sel. Cancer Ther."},{"key":"10.1016\/j.canlet.2023.216066_bib148","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.nano.2017.03.005","article-title":"Evaluation of antitumor activity and cardiac toxicity of a bone-targeted ph-sensitive liposomal formulation in a bone metastasis tumor model in mice","volume":"13","author":"Dos Santos Ferreira","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.canlet.2023.216066_bib149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2021.06.016","article-title":"Breast cancer-derived DAMPs enhance cell invasion and metastasis, while nucleic acid scavengers mitigate these effects","volume":"26","author":"Eteshola","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.canlet.2023.216066_bib150","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1021\/acs.nanolett.8b04757","article-title":"Poly(amidoamine) dendrimer-coordinated copper(II) complexes as a theranostic nanoplatform for the radiotherapy-enhanced magnetic resonance imaging and chemotherapy of tumors and tumor metastasis","volume":"19","author":"Fan","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.canlet.2023.216066_bib151","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/126906","article-title":"Enhanced growth inhibition of osteosarcoma by cytotoxic polymerized liposomal nanoparticles targeting the alcam cell surface receptor","author":"Federman","year":"2012","journal-title":"Sarcoma"},{"key":"10.1016\/j.canlet.2023.216066_bib152","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.2147\/IJN.S150017","article-title":"Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted PEGylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance","volume":"13","author":"Haghiralsadat","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.canlet.2023.216066_bib153","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201902246","article-title":"Targeting of CXCR1 on osteosarcoma circulating tumor cells and precise treatment via cisplatin nanodelivery","volume":"29","author":"Han","year":"2019","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.canlet.2023.216066_bib154","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3109\/10717544.2014.920059","article-title":"Efficient delivery of micro RNA to bone-metastatic prostate tumors by using aptamer-conjugated atelocollagen in vitro and in vivo","volume":"23","author":"Hao","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.canlet.2023.216066_bib155","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.2217\/nnm.15.162","article-title":"On-chip synthesis of fine-tuned bone-seeking hybrid nanoparticles","volume":"10","author":"Hasani-Sadrabadi","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.canlet.2023.216066_bib156","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201705622","article-title":"Rational design of tumor microenvironment\u2010activated micelles for programed targeting of breast cancer metastasis","volume":"28","author":"He","year":"2018","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.canlet.2023.216066_bib157","doi-asserted-by":"crossref","first-page":"8074","DOI":"10.1002\/jcb.26727","article-title":"Integrin alpha V beta 3 targeted dendrimer-rapamycin conjugate reduces fibroblast-mediated prostate tumor progression and metastasis","volume":"119","author":"Hill","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.canlet.2023.216066_bib158","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.ymthe.2020.12.026","article-title":"Controlling cancer-induced inflammation with a nucleic acid scavenger prevents lung metastasis in murine models of breast cancer","volume":"29","author":"Holl","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.canlet.2023.216066_bib159","doi-asserted-by":"crossref","first-page":"7043","DOI":"10.1002\/adma.201503323","article-title":"Anticancer platelet-mimicking nanovehicles","volume":"27","author":"Hu","year":"2015","journal-title":"Adv. Mater."},{"key":"10.1016\/j.canlet.2023.216066_bib160","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa5447","article-title":"Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells","volume":"7","author":"Huang","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2023.216066_bib161","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.biomaterials.2018.02.033","article-title":"Necroptotic cancer cells-mimicry nanovaccine boosts anti-tumor immunity with tailored immune-stimulatory modality","volume":"164","author":"Kang","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2023.216066_bib162","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1021\/acsnano.6b06477","article-title":"Nanoparticles coated with neutrophil membranes can effectively treat cancer metastasis","volume":"11","author":"Kang","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.canlet.2023.216066_bib163","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.biomaterials.2018.02.034","article-title":"Polymeric nanoparticles encapsulating novel TLR7\/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapy","volume":"164","author":"Kim","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2023.216066_bib164","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.1016\/j.actbio.2012.11.013","article-title":"Doxorubicin-conjugated dendrimer\/collagen hybrid gels for metastasis-associated drug delivery systems","volume":"9","author":"Kojima","year":"2013","journal-title":"Acta Biomater."},{"key":"10.1016\/j.canlet.2023.216066_bib165","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41467-017-02758-9","article-title":"Radionuclides transform chemotherapeutics into phototherapeutics for precise treatment of disseminated cancer","volume":"9","author":"Kotagiri","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2023.216066_bib166","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature18300","article-title":"Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy","volume":"534","author":"Kranz","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2023.216066_bib167","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/cas.14264","article-title":"Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: subgroup analysis of the NAPOLI-1 study","volume":"111","author":"Bang","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2023.216066_bib168","article-title":"Targeted therapy against metastatic melanoma based on self-assembled metal-phenolic nanocomplexes comprised of green tea catechin","volume":"6","author":"Li","year":"2019","journal-title":"Adv. Sci."},{"key":"10.1016\/j.canlet.2023.216066_bib169","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nnano.2015.292","article-title":"In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer","volume":"11","author":"Lizotte","year":"2016","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.canlet.2023.216066_bib170","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12951-021-00966-6","article-title":"Curcumin loaded sub-30 nm targeting therapeutic lipid nanoparticles for synergistically blocking nasopharyngeal cancer growth and metastasis","volume":"19","author":"Luo","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.canlet.2023.216066_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119464","article-title":"Engineered nano-immunopotentiators efficiently promote cancer immunotherapy for inhibiting and preventing lung metastasis of melanoma","volume":"223","author":"Luo","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2023.216066_bib172","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1016\/j.biomaterials.2013.01.052","article-title":"Poly(ethylene glycol)-paclitaxel-alendronate self-assembled micelles for the targeted treatment of breast cancer bone metastases","volume":"34","author":"Miller","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2023.216066_bib173","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/adhm.201300465","article-title":"Osteotropic therapy via targeted layer-by-layer nanoparticles","volume":"3","author":"Morton","year":"2014","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.canlet.2023.216066_bib174","doi-asserted-by":"crossref","first-page":"9343","DOI":"10.1073\/pnas.0803728105","article-title":"Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis","volume":"105","author":"Murphy","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2023.216066_bib175","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1158\/1535-7163.MCT-17-0981","article-title":"Scavenger receptor type B1 and lipoprotein nanoparticle inhibit myeloid-derived suppressor cells","volume":"17","author":"Plebanek","year":"2018","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2023.216066_bib176","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jconrel.2011.11.020","article-title":"Bone metastasis targeting: a novel approach to reach bone using Zoledronate anchored PLGA nanoparticle as carrier system loaded with Docetaxel","volume":"158","author":"Ramanlal Chaudhari","year":"2012","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.canlet.2023.216066_bib177","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201905233","article-title":"Nanoparticle conjugation of ginsenoside Rg3 inhibits hepatocellular carcinoma development and metastasis","volume":"16","author":"Ren","year":"2020","journal-title":"Small"},{"key":"10.1016\/j.canlet.2023.216066_bib178","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1158\/0008-5472.CAN-17-1225","article-title":"Bone-induced expression of integrin beta3 enables targeted nanotherapy of breast cancer metastases","volume":"77","author":"Ross","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2023.216066_bib179","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jconrel.2018.02.008","article-title":"Colorectal cancer lung metastasis treatment with polymer-drug nanoparticles","volume":"275","author":"Rychahou","year":"2018","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.canlet.2023.216066_bib180","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2174\/156800910793605767","article-title":"Bone-targeted doxorubicin-loaded nanoparticles as a tool for the treatment of skeletal metastases","volume":"10","author":"Salerno","year":"2010","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.canlet.2023.216066_bib181","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41551-017-0130-9","article-title":"A non-cytotoxic dendrimer with innate and potent anticancer and anti-metastatic activities","volume":"1","author":"Shao","year":"2017","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.canlet.2023.216066_bib182","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1021\/acsabm.0c01599","article-title":"Development of a PAMAM dendrimer for sustained release of temozolomide against experimental murine lymphoma: assessment of therapeutic efficacy","volume":"4","author":"Sk","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.canlet.2023.216066_bib183","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.1021\/acsnano.9b00097","article-title":"Bone-targeted nanoplatform combining zoledronate and photothermal therapy to treat breast cancer bone metastasis","volume":"13","author":"Sun","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.canlet.2023.216066_bib184","doi-asserted-by":"crossref","first-page":"10287","DOI":"10.1073\/pnas.1401337111","article-title":"Engineered nanomedicine for myeloma and bone microenvironment targeting","volume":"111","author":"Swami","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2023.216066_bib185","doi-asserted-by":"crossref","first-page":"7164","DOI":"10.1016\/j.biomaterials.2012.06.026","article-title":"Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer","volume":"33","author":"Thamake","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2023.216066_bib186","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1111\/cas.12553","article-title":"Photodynamic therapy using nanoparticle loaded with indocyanine green for experimental peritoneal dissemination of gastric cancer","volume":"105","author":"Tsujimoto","year":"2014","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2023.216066_bib187","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1021\/acsnano.9b04571","article-title":"Tuning ligand density to optimize pharmacokinetics of targeted nanoparticles for dual protection against tumor-induced bone destruction","volume":"14","author":"Vanderburgh","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.canlet.2023.216066_bib188","doi-asserted-by":"crossref","first-page":"4964","DOI":"10.1038\/s41467-021-25197-z","article-title":"An amphiphilic dendrimer as a light-activable immunological adjuvant for in situ cancer vaccination","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2023.216066_bib189","doi-asserted-by":"crossref","first-page":"41003","DOI":"10.1021\/acsami.8b07527","article-title":"A targeted and pH-responsive bortezomib nanomedicine in the treatment of metastatic bone tumors","volume":"10","author":"Wang","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.canlet.2023.216066_bib190","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.biomaterials.2016.11.010","article-title":"Osteotropic peptide-mediated bone targeting for photothermal treatment of bone tumors","volume":"114","author":"Wang","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2023.216066_bib191","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.nano.2015.02.010","article-title":"Safe lipid nanocapsule-based gel technology to target lymph nodes and combat mediastinal metastases from an orthotopic non-small-cell lung cancer model in SCID-CB17 mice","volume":"11","author":"Wauthoz","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.canlet.2023.216066_bib192","doi-asserted-by":"crossref","first-page":"9648","DOI":"10.1016\/j.biomaterials.2013.08.056","article-title":"Nanodiamonds-mediated doxorubicin nuclear delivery to inhibit lung metastasis of breast cancer","volume":"34","author":"Xiao","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2023.216066_bib193","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.actbio.2019.09.005","article-title":"Zwitterion-functionalized dendrimer-entrapped gold nanoparticles for serum-enhanced gene delivery to inhibit cancer cell metastasis","volume":"99","author":"Xiong","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.canlet.2023.216066_bib194","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.biomaterials.2015.06.017","article-title":"Shrapnel nanoparticles loading docetaxel inhibit metastasis and growth of breast cancer","volume":"64","author":"Xu","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2023.216066_bib195","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jconrel.2013.08.021","article-title":"Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis","volume":"172","author":"Xu","year":"2013","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.canlet.2023.216066_bib196","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1080\/1061186X.2018.1434659","article-title":"Bone-targeting dendrimer for the delivery of methotrexate and treatment of bone metastasis","volume":"26","author":"Yamashita","year":"2018","journal-title":"J. Drug Target."},{"key":"10.1016\/j.canlet.2023.216066_bib197","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/acsami.8b15827","article-title":"A carboxyl-terminated dendrimer enables osteolytic lesion targeting and photothermal ablation of malignant bone tumors","volume":"11","author":"Yan","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.canlet.2023.216066_bib198","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.7150\/thno.54930","article-title":"Dual-mode endogenous and exogenous sensitization of tumor radiotherapy through antifouling dendrimer-entrapped gold nanoparticles","volume":"11","author":"Yang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2023.216066_bib199","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2019.03.024","article-title":"Bioinspired nanoplatelets for chemo-photothermal therapy of breast cancer metastasis inhibition","volume":"206","author":"Ye","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2023.216066_bib200","doi-asserted-by":"crossref","first-page":"E4601","DOI":"10.1073\/pnas.1603316113","article-title":"Pamidronate functionalized nanoconjugates for targeted therapy of focal skeletal malignant osteolysis","volume":"113","author":"Yin","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2023.216066_bib201","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/s41467-020-14906-9","article-title":"Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response","volume":"11","author":"Yu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2023.216066_bib202","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3171\/2014.2.SPINE13142","article-title":"Characterization of intratumor magnetic nanoparticle distribution and heating in a rat model of metastatic spine disease","volume":"20","author":"Zadnik","year":"2014","journal-title":"J. Neurosurg. Spine"},{"key":"10.1016\/j.canlet.2023.216066_bib203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2019.12.005","article-title":"Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis","volume":"318","author":"Zhao","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.canlet.2023.216066_bib204","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1039\/C7NR00962C","article-title":"Redox and pH dual sensitive bone targeting nanoparticles to treat breast cancer bone metastases and inhibit bone resorption","volume":"9","author":"Zhao","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.canlet.2023.216066_bib205","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.biomaterials.2018.12.024","article-title":"One stone with two birds: phytic acid-capped platinum nanoparticles for targeted combination therapy of bone tumors","volume":"194","author":"Zhou","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2023.216066_bib206","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201901866","article-title":"Targeted delivery of secretory promelittin via novel poly(lactone-co-beta-amino ester) nanoparticles for treatment of breast cancer brain metastases","volume":"7","author":"Zhou","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.canlet.2023.216066_bib207","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2016.02.035","article-title":"Lipid-enveloped zinc phosphate hybrid nanoparticles for codelivery of H-2K(b) and H-2D(b)-restricted antigenic peptides and monophosphoryl lipid A to induce antitumor immunity against melanoma","volume":"228","author":"Zhuang","year":"2016","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.canlet.2023.216066_bib208","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.breast.2011.07.005","article-title":"Weekly nab-paclitaxel is safe and effective in >\/=65 years old patients with metastatic breast cancer: a post-hoc analysis","volume":"20","author":"Aapro","year":"2011","journal-title":"Breast"},{"key":"10.1016\/j.canlet.2023.216066_bib209","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10637-019-00747-x","article-title":"Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma","volume":"37","author":"Akiyama","year":"2019","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.canlet.2023.216066_bib210","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/CMR.0000000000000062","article-title":"Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-alpha in patients with metastatic melanoma","volume":"24","author":"Alrwas","year":"2014","journal-title":"Melanoma Res."},{"key":"10.1016\/j.canlet.2023.216066_bib211","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00280-011-1726-5","article-title":"Phase I and pharmacokinetic study of nab-paclitaxel, nanoparticle albumin-bound paclitaxel, administered weekly to Japanese patients with solid tumors and metastatic breast cancer","volume":"69","author":"Ando","year":"2012","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.canlet.2023.216066_bib212","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jamaoncol.2018.2168","article-title":"Safety and efficacy of BIND-014, a docetaxel nanoparticle targeting prostate-specific membrane antigen for patients with metastatic castration-resistant prostate cancer: a phase 2 clinical trial","volume":"4","author":"Autio","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib213","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3816\/CBC.2007.n.049","article-title":"Phase II study of weekly albumin-bound paclitaxel for patients with metastatic breast cancer heavily pretreated with taxanes","volume":"7","author":"Blum","year":"2007","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.canlet.2023.216066_bib214","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1158\/1078-0432.CCR-20-0591","article-title":"A phase 1b dose escalation trial of NC-6300 (nanoparticle epirubicin) in patients with advanced solid tumors or advanced, metastatic, or unresectable soft-tissue sarcoma","volume":"26","author":"Chawla","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2023.216066_bib215","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.pan.2020.10.029","article-title":"Early dose reduction\/delay and the efficacy of liposomal irinotecan with fluorouracil and leucovorin in metastatic pancreatic ductal adenocarcinoma (mPDAC): a post hoc analysis of NAPOLI-1","volume":"21","author":"Chen","year":"2021","journal-title":"Pancreatology"},{"key":"10.1016\/j.canlet.2023.216066_bib216","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejca.2018.09.010","article-title":"Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: expanded analysis of a global phase 3 trial","volume":"105","author":"Chen","year":"2018","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2023.216066_bib217","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3816\/CBC.2010.n.036","article-title":"Phase II trial of weekly nanoparticle albumin-bound paclitaxel with carboplatin and trastuzumab as first-line therapy for women with HER2-overexpressing metastatic breast cancer","volume":"10","author":"Conlin","year":"2010","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.canlet.2023.216066_bib218","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2217\/fon-2019-0742","article-title":"Nanoparticle albumin-bound paclitaxel\/liposomal-encapsulated doxorubicin in HER2-negative metastatic breast cancer patients","volume":"16","author":"Fabi","year":"2020","journal-title":"Future Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib219","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/annonc\/mdr300","article-title":"Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasis","volume":"23","author":"Fasol","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib220","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41416-019-0391-z","article-title":"A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients","volume":"120","author":"Fujiwara","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2023.216066_bib221","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.1200\/JCO.2005.04.937","article-title":"Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer","volume":"23","author":"Gradishar","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib222","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00280-018-3654-0","article-title":"A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc( )) in patients with locally advanced or metastatic cancer","volume":"82","author":"Greil","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.canlet.2023.216066_bib223","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/A:1008386822906","article-title":"A phase II study of pegylated liposomal doxorubicin for treatment of advanced hepatocellular carcinoma","volume":"11","author":"Halm","year":"2000","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib224","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00280-018-3693-6","article-title":"A phase II study of NK012, a polymeric micelle formulation of SN-38, in unresectable, metastatic or recurrent colorectal cancer patients","volume":"82","author":"Hamaguchi","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.canlet.2023.216066_bib225","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s10637-010-9455-x","article-title":"A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal(R) dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC)","volume":"29","author":"Harrison","year":"2011","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.canlet.2023.216066_bib226","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1111\/cas.13813","article-title":"Phase II clinical trial of S-1 plus nanoparticle albumin-bound paclitaxel in untreated patients with metastatic gastric cancer","volume":"109","author":"He","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2023.216066_bib227","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/cncr.24720","article-title":"A phase 2 clinical trial of nab-paclitaxel in previously treated and chemotherapy-naive patients with metastatic melanoma","volume":"116","author":"Hersh","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2023.216066_bib228","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejca.2018.09.029","article-title":"Quality of life in metastatic pancreatic cancer patients receiving liposomal irinotecan plus 5-fluorouracil and leucovorin","volume":"106","author":"Hubner","year":"2019","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2023.216066_bib229","doi-asserted-by":"crossref","DOI":"10.1177\/17588359211056179","article-title":"Gemcitabine plus Nab-paclitaxel as a second-line treatment following FOLFIRINOX failure in advanced pancreatic cancer: a multicenter, single-arm, open-label, phase 2 trial","volume":"13","author":"Huh","year":"2021","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.canlet.2023.216066_bib230","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.1200\/JCO.2005.11.013","article-title":"Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancer","volume":"23","author":"Ibrahim","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib231","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1200\/JCO.2004.08.157","article-title":"Randomized phase III trial of pegylated liposomal doxorubicin versus vinorelbine or mitomycin C plus vinblastine in women with taxane-refractory advanced breast cancer","volume":"22","author":"Keller","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib232","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.21873\/anticanres.11471","article-title":"Multicenter phase II clinical trial of genexol-PM(R) with gemcitabine in advanced biliary tract cancer","volume":"37","author":"Kim","year":"2017","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2023.216066_bib233","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1002\/cncr.25659","article-title":"A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group Study, N057E(1)","volume":"117","author":"Kottschade","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2023.216066_bib234","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000087908","article-title":"Phase I study of weekly docetaxel and liposomal doxorubicin in patients with advanced solid tumors","volume":"69","author":"Kouroussis","year":"2005","journal-title":"Oncology"},{"key":"10.1016\/j.canlet.2023.216066_bib235","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/neuonc\/noz201","article-title":"Intrathecal liposomal cytarabine plus systemic therapy versus systemic chemotherapy alone for newly diagnosed leptomeningeal metastasis from breast cancer","volume":"22","author":"Le Rhun","year":"2020","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib236","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1158\/1078-0432.CCR-16-3193","article-title":"64)Cu-MM-302 positron emission tomography quantifies variability of enhanced permeability and retention of nanoparticles in relation to treatment response in patients with metastatic breast cancer","volume":"23","author":"Lee","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2023.216066_bib237","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10549-007-9591-y","article-title":"Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer","volume":"108","author":"Lee","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.canlet.2023.216066_bib238","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3816\/CBC.2004.n.041","article-title":"Phase II study of pegylated liposomal doxorubicin plus vinorelbine in breast cancer with previous anthracycline exposure","volume":"5","author":"Martin","year":"2004","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.canlet.2023.216066_bib239","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/s12885-016-2385-z","article-title":"HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician's choice plus trastuzumab in patients with previously treated, anthracycline-naive, HER2-positive, locally advanced\/metastatic breast cancer","volume":"16","author":"Miller","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2023.216066_bib240","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.clbc.2011.03.007","article-title":"A phase II study of weekly nanoparticle albumin-bound paclitaxel with or without trastuzumab in metastatic breast cancer","volume":"11","author":"Mirtsching","year":"2011","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.canlet.2023.216066_bib241","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/annonc\/mdi209","article-title":"Phase I trial of liposomal encapsulated doxorubicin (Myocet; D-99) and weekly docetaxel in advanced breast cancer patients","volume":"16","author":"Mrozek","year":"2005","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib242","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.clbc.2019.04.004","article-title":"Phase II study of systemic high-dose methotrexate and intrathecal liposomal cytarabine for treatment of leptomeningeal carcinomatosis from breast cancer","volume":"19","author":"Mrugala","year":"2019","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.canlet.2023.216066_bib243","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000509396","article-title":"Phase 1 study of combined chemotherapy of nab-paclitaxel, S-1, and oxaliplatin for gastric cancer with peritoneal metastasis (NSOX study)","volume":"99","author":"Nakamura","year":"2021","journal-title":"Oncology"},{"key":"10.1016\/j.canlet.2023.216066_bib244","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1182\/blood-2004-07-2911","article-title":"Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies","volume":"105","author":"Orlowski","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2023.216066_bib245","doi-asserted-by":"crossref","first-page":"6903","DOI":"10.21873\/anticanres.13910","article-title":"Phase I study of combination therapy with weekly nanoparticle albumin-bound paclitaxel and cyclophosphamide in metastatic breast cancer patients","volume":"39","author":"Ota","year":"2019","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2023.216066_bib246","doi-asserted-by":"crossref","first-page":"569","DOI":"10.4143\/crt.2016.289","article-title":"An open-label, randomized, parallel, phase III trial evaluating the efficacy and safety of polymeric micelle-formulated paclitaxel compared to conventional cremophor EL-based paclitaxel for recurrent or metastatic HER2-negative breast cancer","volume":"49","author":"Park","year":"2017","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.canlet.2023.216066_bib247","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1038\/mt.2016.135","article-title":"Safety and efficacy in advanced solid tumors of a targeted nanocomplex carrying the p53 gene used in combination with docetaxel: a phase 1b study","volume":"24","author":"Pirollo","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.canlet.2023.216066_bib248","first-page":"1817","article-title":"Paclitaxel and liposomal doxorubicin (Caelyx) combination in advanced breast cancer patients: a phase II study","volume":"10","author":"Rigatos","year":"2003","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2023.216066_bib249","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/annonc\/mdq392","article-title":"Weekly combination of non-pegylated liposomal doxorubicin and taxane in first-line breast cancer: wALT trial (phase I-II)","volume":"22","author":"Rosati","year":"2011","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib250","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/annonc\/mdn661","article-title":"Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane) in combination with gemcitabine in patients with metastatic breast cancer (N0531)","volume":"20","author":"Roy","year":"2009","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib251","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1200\/JCO.2014.59.5298","volume":"33","author":"Rugo","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib252","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/jamaoncol.2018.3277","article-title":"Nab-paclitaxel and gemcitabine as first-line treatment of advanced or metastatic cholangiocarcinoma: a phase 2 clinical trial","volume":"4","author":"Sahai","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib253","doi-asserted-by":"crossref","first-page":"6515","DOI":"10.21873\/anticanres.11252","article-title":"Phase I study of triweekly nab-paclitaxel combined with S-1 in patients with HER2-negative metastatic breast cancer","volume":"36","author":"Sakaguchi","year":"2016","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2023.216066_bib254","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jamaoncol.2016.6007","article-title":"Topical imiquimod plus nab-paclitaxel for breast cancer cutaneous metastases: a phase 2 clinical trial","volume":"3","author":"Salazar","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib255","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1200\/JCO.2013.55.0376","article-title":"First-in-human phase I study of the liposomal RNA interference therapeutic Atu027 in patients with advanced solid tumors","volume":"32","author":"Schultheis","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib256","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.clbc.2013.02.008","article-title":"Randomized phase II trial of weekly vs. every 2 weeks vs. every 3 weeks nanoparticle albumin-bound paclitaxel with bevacizumab as first-line chemotherapy for metastatic breast cancer","volume":"13","author":"Seidman","year":"2013","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.canlet.2023.216066_bib257","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/j.clinthera.2013.10.009","article-title":"Bioequivalence of Liposome-Entrapped Paclitaxel Easy-To-Use (LEP-ETU) formulation and paclitaxel in polyethoxylated castor oil: a randomized, two-period crossover study in patients with advanced cancer","volume":"35","author":"Slingerland","year":"2013","journal-title":"Clin. Therapeut."},{"key":"10.1016\/j.canlet.2023.216066_bib258","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1158\/1078-0432.CCR-17-1114","article-title":"Phase ib\/II trial of NC-6004 (nanoparticle cisplatin) plus gemcitabine in patients with advanced solid tumors","volume":"24","author":"Subbiah","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2023.216066_bib259","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10120-018-0838-6","article-title":"Peritoneal metastasis as a predictive factor for nab-paclitaxel in patients with pretreated advanced gastric cancer: an exploratory analysis of the phase III ABSOLUTE trial","volume":"22","author":"Takashima","year":"2019","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.canlet.2023.216066_bib260","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1158\/1078-0432.CCR-08-1599","article-title":"Phase I trial of 2-methoxyestradiol NanoCrystal dispersion in advanced solid malignancies","volume":"15","author":"Tevaarwerk","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2023.216066_bib261","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.breast.2020.12.002","article-title":"Randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer","volume":"55","author":"Tsurutani","year":"2021","journal-title":"Breast"},{"key":"10.1016\/j.canlet.2023.216066_bib262","doi-asserted-by":"crossref","first-page":"9396","DOI":"10.1002\/cam4.3558","article-title":"nal-IRI+5-FU\/LV versus 5-FU\/LV in post-gemcitabine metastatic pancreatic cancer: randomized phase 2 trial in Japanese patients","volume":"9","author":"Ueno","year":"2020","journal-title":"Cancer Med."},{"key":"10.1016\/j.canlet.2023.216066_bib263","doi-asserted-by":"crossref","DOI":"10.1515\/pp-2018-0112","article-title":"Intraperitoneal aerosolization of albumin-stabilized paclitaxel nanoparticles (Abraxane) for peritoneal carcinomatosis - a phase I first-in-human study","volume":"3","author":"Van De Sande","year":"2018","journal-title":"Pleura Peritoneum"},{"key":"10.1016\/j.canlet.2023.216066_bib264","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00066-006-1440-0","article-title":"Phase I\/II trial of external irradiation plus medium-dose brachytherapy given concurrently to liposomal doxorubicin and cisplatin for advanced uterine cervix carcinoma","volume":"182","author":"Varveris","year":"2006","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.canlet.2023.216066_bib265","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.radonc.2021.04.021","article-title":"Theranostic AGuIX nanoparticles as radiosensitizer: a phase I, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial)","volume":"160","author":"Verry","year":"2021","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib266","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1158\/1078-0432.CCR-0929-3","article-title":"Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20(s)-camptothecin in patients with advanced pulmonary malignancies","volume":"10","author":"Verschraegen","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2023.216066_bib267","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2023.216066_bib268","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1093\/annonc\/mdx493","article-title":"A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma","volume":"28","author":"Voss","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib269","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejca.2021.03.028","article-title":"First-line liposomal irinotecan with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) in pancreatic ductal adenocarcinoma: a phase I\/II study","volume":"151","author":"Wainberg","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2023.216066_bib270","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s10637-021-01182-7","article-title":"Efficacy and safety of mitoxantrone hydrochloride liposome injection in Chinese patients with advanced breast cancer: a randomized, open-label, active-controlled, single-center, phase II clinical trial","volume":"40","author":"Wang","year":"2022","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.canlet.2023.216066_bib271","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00280-014-2523-8","article-title":"Phase I clinical trial of pegylated liposomal mitoxantrone plm60-s: pharmacokinetics, toxicity and preliminary efficacy","volume":"74","author":"Yang","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.canlet.2023.216066_bib272","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/S1470-2045(21)00486-1","article-title":"Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliary tract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study","volume":"22","author":"Yoo","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib273","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00280-016-3091-x","article-title":"A phase 1, dose-finding and pharmacokinetic study of gemcitabine with nab-paclitaxel in patients with metastatic breast cancer","volume":"78","author":"Yoshitomi","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.canlet.2023.216066_bib274","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1186\/s12885-018-4936-y","article-title":"Caveolin-1 expression predicts efficacy of weekly nab-paclitaxel plus gemcitabine for metastatic breast cancer in the phase II clinical trial","volume":"18","author":"Zhao","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2023.216066_bib275","article-title":"Epidemiology of bone metastases","author":"Ryan","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.canlet.2023.216066_bib276","doi-asserted-by":"crossref","first-page":"482","DOI":"10.21037\/atm.2020.03.55","article-title":"Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study","volume":"8","author":"Huang","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.canlet.2023.216066_bib277","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1126\/science.289.5484.1508","article-title":"Therapeutic approaches to bone diseases","volume":"289","author":"Rodan","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.canlet.2023.216066_bib278","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nrurol.2015.90","article-title":"Targeting bone metastases in prostate cancer: improving clinical outcome","volume":"12","author":"Body","year":"2015","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.canlet.2023.216066_bib279","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejrnm.2017.09.006","article-title":"Outcomes of embolization of bone tumors in the pelvic and shoulder girdles: initial experience","volume":"49","author":"Abd El-khalek","year":"2018","journal-title":"The Egyptian Journal of Radiology and Nuclear Medicine"},{"key":"10.1016\/j.canlet.2023.216066_bib280","first-page":"H278","article-title":"E-selectin-targeted porous silicon particle for nanoparticle delivery to the bone marrow","volume":"23","author":"Mann","year":"2011","journal-title":"Adv. Mater."},{"key":"10.1016\/j.canlet.2023.216066_bib281","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/ijc.24890","article-title":"Sustained delivery and efficacy of polymeric nanoparticles containing osteopontin and bone sialoprotein antisenses in rats with breast cancer bone metastasis","volume":"126","author":"Elazar","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2023.216066_bib282","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1474-4422(05)70072-7","article-title":"Therapeutic management of brain metastasis","volume":"4","author":"Kaal","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.canlet.2023.216066_bib283","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s11912-022-01237-9","article-title":"Emerging studies of melanoma brain metastasis","volume":"24","author":"Caulfield","year":"2022","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.canlet.2023.216066_bib284","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/CMR.0000000000000538","article-title":"Incidence and prognosis of brain metastases in cutaneous melanoma patients: a population-based study","volume":"29","author":"Zhang","year":"2019","journal-title":"Melanoma Res."},{"key":"10.1016\/j.canlet.2023.216066_bib285","doi-asserted-by":"crossref","first-page":"432","DOI":"10.6004\/jnccn.2020.7634","article-title":"Prognosis of incidental brain metastases in patients with advanced renal cell carcinoma","volume":"19","author":"Kotecha","year":"2021","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.canlet.2023.216066_bib286","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s10147-021-02049-w","article-title":"HER2-low breast cancer could be associated with an increased risk of brain metastasis","volume":"27","author":"Guven","year":"2022","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib287","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1522-2586(199902)9:2<228::AID-JMRI12>3.0.CO;2-K","article-title":"Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent","volume":"9","author":"Enochs","year":"1999","journal-title":"J. Magn. Reson. Imag."},{"key":"10.1016\/j.canlet.2023.216066_bib288","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.addr.2020.12.002","article-title":"Brain metastasis models: what should we aim to achieve better treatments?","volume":"169","author":"Masmudi-Martin","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.canlet.2023.216066_bib289","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrd1414","article-title":"Targeted therapy for brain tumours","volume":"3","author":"Lesniak","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2023.216066_bib290","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41416-020-01175-y","article-title":"Treatment strategies for breast cancer brain metastases","volume":"124","author":"Bailleux","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2023.216066_bib291","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/cncr.24735","article-title":"Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but not HER2\/neu-positive breast cancer","volume":"116","author":"Yonemori","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2023.216066_bib292","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102324","article-title":"Targeting brain metastases in breast cancer","volume":"103","author":"Corti","year":"2022","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.canlet.2023.216066_bib293","doi-asserted-by":"crossref","first-page":"6200","DOI":"10.1158\/0008-5472.CAN-09-1157","article-title":"Specific targeting of brain tumors with an optical\/magnetic resonance imaging nanoprobe across the blood-brain barrier","volume":"69","author":"Veiseh","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2023.216066_bib294","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1023\/A:1010931127745","article-title":"Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery","volume":"18","author":"Calvo","year":"2001","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.canlet.2023.216066_bib295","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0026-895X(24)26466-X","article-title":"New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy","volume":"57","author":"Rousselle","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.canlet.2023.216066_bib296","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/10611860400015936","article-title":"Nanoparticle surface charges alter blood-brain barrier integrity and permeability","volume":"12","author":"Lockman","year":"2004","journal-title":"J. Drug Target."},{"key":"10.1016\/j.canlet.2023.216066_bib297","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1124\/jpet.105.097139","article-title":"Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain","volume":"317","author":"Michaelis","year":"2006","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.canlet.2023.216066_bib298","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/10611860290031877","article-title":"Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier","volume":"10","author":"Kreuter","year":"2002","journal-title":"J. Drug Target."},{"key":"10.1016\/j.canlet.2023.216066_bib299","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/17425247.2019.1583205","article-title":"Blood-brain barrier receptors and transporters: an insight on their function and how to exploit them through nanotechnology","volume":"16","author":"Moura","year":"2019","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.canlet.2023.216066_bib300","doi-asserted-by":"crossref","first-page":"14164","DOI":"10.1073\/pnas.93.24.14164","article-title":"Brain drug delivery of small molecules using immunoliposomes","volume":"93","author":"Huwyler","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2023.216066_bib301","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2217\/nnm.14.27","article-title":"Targeting nanoparticles across the blood\u2013brain barrier with monoclonal antibodies","volume":"9","author":"Loureiro","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.canlet.2023.216066_bib302","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.canlet.2023.216066_bib303","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3109\/02656736.2014.936049","article-title":"Two phase I dose-escalation\/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer","volume":"30","author":"Zagar","year":"2014","journal-title":"Int. J. Hyperther."},{"key":"10.1016\/j.canlet.2023.216066_bib304","first-page":"119","article-title":"Skin metastases in cancer patients","volume":"39","author":"Spencer","year":"1987","journal-title":"Cutis"},{"key":"10.1016\/j.canlet.2023.216066_bib305","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s12094-006-0178-6","article-title":"Cutaneous metastases of lung cancer","volume":"8","author":"Molina Garrido","year":"2006","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib306","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00432-008-0432-0","article-title":"Cutaneous metastases of visceral tumours: a review","volume":"135","author":"Nashan","year":"2009","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib307","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13215416","article-title":"Clinical, pathological, and molecular features of breast carcinoma cutaneous metastasis","volume":"13","author":"Gonzalez-Martinez","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2023.216066_bib308","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/jso.21816","article-title":"Cutaneous melanoma: a model to study cancer metastasis","volume":"103","author":"Leong","year":"2011","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib309","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4103\/1947-2714.118918","article-title":"The presentation, pathology, and current management strategies of cutaneous metastasis","volume":"5","author":"Wong","year":"2013","journal-title":"N. Am. J. Med. Sci."},{"key":"10.1016\/j.canlet.2023.216066_bib310","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.2217\/nnm.14.128","article-title":"Nanomedicine strategies for hematological malignancies: what is next?","volume":"9","author":"Visani","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.canlet.2023.216066_bib311","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jconrel.2018.08.034","article-title":"Nanomedicines for the treatment of hematological malignancies","volume":"287","author":"Deshantri","year":"2018","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.canlet.2023.216066_bib312","doi-asserted-by":"crossref","first-page":"48","DOI":"10.21037\/cco.2018.08.12","article-title":"Hepatocellular carcinoma surgical therapy: perspectives on the current limits to resection","volume":"7","author":"Chawla","year":"2018","journal-title":"Chin. Clin. Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib313","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.589680","article-title":"Immunotherapy for hepatocellular carcinoma: current limits and prospects","volume":"11","author":"Zhong","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib314","doi-asserted-by":"crossref","first-page":"907","DOI":"10.4254\/wjh.v9.i21.907","article-title":"Chemotherapy for hepatocellular carcinoma: the present and the future","volume":"9","author":"Le Grazie","year":"2017","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.canlet.2023.216066_bib315","first-page":"235","article-title":"Chemotherapy for hepatocellular carcinoma: current evidence and future perspectives","volume":"5","author":"Rinninella","year":"2017","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.canlet.2023.216066_bib316","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/nnano.2016.168","article-title":"Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues","volume":"11","author":"Zanganeh","year":"2016","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.canlet.2023.216066_bib317","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.addr.2007.11.006","article-title":"Targeted delivery of nanoparticles for the treatment of lung diseases","volume":"60","author":"Azarmi","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.canlet.2023.216066_bib318","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.biomaterials.2010.09.014","article-title":"Targeting of polymeric nanoparticles to lung metastases by surface-attachment of YIGSR peptide from laminin","volume":"32","author":"Sarfati","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2023.216066_bib319","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/01.sla.0000197702.46394.16","article-title":"Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies","volume":"243","author":"Koppe","year":"2006","journal-title":"Ann. Surg."},{"key":"10.1016\/j.canlet.2023.216066_bib320","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1200\/JOP.2017.022210","article-title":"Management of malignant bowel obstruction associated with GI cancers","volume":"13","author":"Franke","year":"2017","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.canlet.2023.216066_bib321","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1067\/mcn.2002.129579","article-title":"Pancreatic cancer","volume":"26","author":"Yeo","year":"2002","journal-title":"Curr. Probl. Cancer"},{"key":"10.1016\/j.canlet.2023.216066_bib322","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/j.seminoncol.2018.12.003","article-title":"Systemic treatment of pancreatic cancer revisited","volume":"46","author":"Ducreux","year":"2019","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib323","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1245\/s10434-013-3289-7","article-title":"Intensity of follow-up after pancreatic cancer resection","volume":"21","author":"Castellanos","year":"2014","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.canlet.2023.216066_bib324","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.canlet.2023.216066_bib325","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1200\/OP.21.00206","article-title":"Recent advances in the management of metastatic prostate cancer","volume":"18","author":"Sayegh","year":"2022","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.canlet.2023.216066_bib326","first-page":"7","article-title":"Cancer statistics","volume":"66","author":"Siegel","year":"2016","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.canlet.2023.216066_bib327","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/cncr.30328","article-title":"A phase 2 study of nanoparticle albumin-bound paclitaxel plus nedaplatin for patients with advanced, recurrent, or metastatic cervical carcinoma","volume":"123","author":"Li","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2023.216066_bib328","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1021\/mp800049w","article-title":"Pharmacokinetics and biodistribution of nanoparticles","volume":"5","author":"Li","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.canlet.2023.216066_bib329","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/22\/11\/115101","article-title":"The effects of particle size, density and shape on margination of nanoparticles in microcirculation","volume":"22","author":"Toy","year":"2011","journal-title":"Nanotechnology"},{"key":"10.1016\/j.canlet.2023.216066_bib330","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2006.01.006","article-title":"In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles","volume":"112","author":"Reddy","year":"2006","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.canlet.2023.216066_bib331","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1021\/nn300149c","article-title":"Synthesis and biological response of size-specific, monodisperse drug-silica nanoconjugates","volume":"6","author":"Tang","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/j.canlet.2023.216066_bib332","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113909","article-title":"Advances of nanomedicines in breast cancer metastasis treatment targeting different metastatic stages","volume":"178","author":"Yu","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.canlet.2023.216066_bib333","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1021\/ar200017e","article-title":"Lipoprotein-inspired nanoparticles for cancer theranostics","volume":"44","author":"Ng","year":"2011","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.canlet.2023.216066_bib334","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics8020017","article-title":"Nanomilling of drugs for bioavailability enhancement: a holistic formulation-process perspective","volume":"8","author":"Li","year":"2016","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.canlet.2023.216066_bib335","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40824-018-0133-y","article-title":"New opportunities for nanoparticles in cancer immunotherapy","volume":"22","author":"Park","year":"2018","journal-title":"Biomater. Res."},{"key":"10.1016\/j.canlet.2023.216066_bib336","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1021\/bc049951i","article-title":"Toxicity of gold nanoparticles functionalized with cationic and anionic side chains","volume":"15","author":"Goodman","year":"2004","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.canlet.2023.216066_bib337","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Owens","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.canlet.2023.216066_bib338","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1254\/jphs.FPJ04001X","article-title":"A pegylated liposomal platform: pharmacokinetics, pharmacodynamics, and toxicity in mice using doxorubicin as a model drug","volume":"95","author":"Lu","year":"2004","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.canlet.2023.216066_bib339","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0168-3659(99)00166-2","article-title":"Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes","volume":"63","author":"Crosasso","year":"2000","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.canlet.2023.216066_bib340","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.plipres.2004.12.001","article-title":"Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release","volume":"44","author":"Andresen","year":"2005","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.canlet.2023.216066_bib341","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0169-409X(99)00035-6","article-title":"Cytosolic drug delivery using pH- and light-sensitive liposomes","volume":"38","author":"Gerasimov","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.canlet.2023.216066_bib342","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(03)00232-3","article-title":"Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids","volume":"91","author":"Shin","year":"2003","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.canlet.2023.216066_bib343","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0005-2736(01)00409-6","article-title":"Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells","volume":"1515","author":"Ishida","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2023.216066_bib344","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1158\/1078-0432.CCR-06-0226","article-title":"Phase I trial of doxorubicin-containing low temperature sensitive liposomes in spontaneous canine tumors","volume":"12","author":"Hauck","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2023.216066_bib345","first-page":"6950","article-title":"Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release","volume":"60","author":"Kong","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2023.216066_bib346","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0169-409X(01)00233-2","article-title":"The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors","volume":"53","author":"Needham","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.canlet.2023.216066_bib347","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0169-409X(01)00232-0","article-title":"Phototriggering of liposomal drug delivery systems","volume":"53","author":"Shum","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.canlet.2023.216066_bib348","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0169-409X(01)00205-8","article-title":"Enzyme-activated targeting of liposomes","volume":"53","author":"Meers","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.canlet.2023.216066_bib349","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1158\/1535-7163.1451.3.11","article-title":"Secretory phospholipase A2 as a tumor-specific trigger for targeted delivery of a novel class of liposomal prodrug anticancer etherlipids","volume":"3","author":"Jensen","year":"2004","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2023.216066_bib350","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2174\/156720105774370203","article-title":"Triggered activation and release of liposomal prodrugs and drugs in cancer tissue by secretory phospholipase A2","volume":"2","author":"Andresen","year":"2005","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.canlet.2023.216066_bib351","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0005-2736(98)00256-9","article-title":"Elastase activated liposomal delivery to nucleated cells","volume":"1419","author":"Pak","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2023.216066_bib352","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1021\/bc980047y","article-title":"Cholesterol phosphate derivatives: synthesis and incorporation into a phosphatase and calcium-sensitive triggered release liposome","volume":"9","author":"Davis","year":"1998","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.canlet.2023.216066_bib353","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1021\/bc015580j","article-title":"Formation of fibrinogen-based hydrogels using phototriggerable diplasmalogen liposomes","volume":"13","author":"Zhang","year":"2002","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.canlet.2023.216066_bib354","doi-asserted-by":"crossref","first-page":"22977","DOI":"10.1074\/jbc.273.36.22977","article-title":"Vesicle membrane fusion induced by the concerted activities of sphingomyelinase and phospholipase C","volume":"273","author":"Ruiz-Arguello","year":"1998","journal-title":"J. Biol. Chem."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383523000174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383523000174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T16:06:54Z","timestamp":1759594014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383523000174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":354,"alternative-id":["S0304383523000174"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2023.216066","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoparticles in the diagnosis and treatment of cancer metastases: Current and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2023.216066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"216066"}}